MikeLigalig.com

Florida Men's Health Center, a South Florida based men's health and wellness clinic, is proud to announce they are offering free erectile dysfunction medication to all patients.

FORT LAUDERDALE, FLA. (PRWEB) DECEMBER 11, 2020
Florida Men's Health Center, a South Florida based men's health and wellness clinic, is proud to announce they are offering free erectile dysfunction medication to all patients.
Florida Men's Health Center has been South Florida's premier health clinic for men for over 11 years. They specialize in all men's health issues, including weight loss, sexual health, bio-identical hormone replacement, hair loss and much more.
This is an innovate program and the 1st of its kind to help men with erectile and sexual dysfunction issues. The free ED medication will require an office visit so their team of doctors can evaluate the patient and prescribe the proper medication.
The primary ingredients of the ED medication are Sildenafil and Tadalafil.
"We are excited to be the first clinic to offer free ED medication for our patients and we feel this can be an extremely beneficial program for lots of men. Erectile dysfunction can be mental or physical and sometimes medication is needed to help improve a patient's situation and get them back to 100%," Florida Men's Health Co-Founder Erez Cohen said. "With this program, men can receive free medication to treat the issue and have their confidence restored."
The free medicine will include a subscription of 30 tablets that are prescribed monthly. To be eligible, all patients are required to have an office visit.
Florida Men's Health has treated thousands of patients in the South Florida area for a variety of issues. They have a 5-star rating on Google and have been a trusted wellness clinic in the area for over a decade.
To learn more about this program, please visit here or call them directly at 954-509-9111.
About Florida Men's Health Center: Florida Men's Health Center is the top men's health clinic in South Florida, specializing in weight loss, sexual health, bio-identical hormone replacement, hair loss, and testosterone replacement therapy. They treat each patient with the utmost respect and care on the most personal level. You can reach Florida Men's Health at ecohen@floridamenshealth.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

After two years of continuous work on upgrades, the new MedicareFAQ.com is live.

PALM HARBOR, FLA. (PRWEB) DECEMBER 11, 2020
Elite Insurance Partners debuted a new and improved online learning resource center for Medicare beneficiaries, MedicareFAQ.com. The website overhaul and redesign has been an ongoing effort since late 2018.
Now offering an exceptional user experience, MedicareFAQ.com allows beneficiaries and their loved ones to easily access many different Medicare resources. With increased site speed and user-friendly navigation, the site aims to be an asset to anyone needing to learn about Medicare. Users can easily browse articles and find answers to general or specific questions, watch videos, and listen to podcasts on all Medicare topics.
The site offers in-depth information about every part of Medicare, including Medicare Supplements, Medicare Advantage, and Part D plans. FAQ articles and embedded videos supply answers to the most common queries about coverage, enrollment, and more. Easy-to-read infographics are on display to simplify more complex concepts, such as plan comparisons.
"At Elite Insurance Partners, our approach to plan selection focuses on client education first," says CEO, Jagger Esch. "We understand Medicare is complex, so we want to provide the best possible resource to eliminate confusion. After the success MedicareFAQ has already seen in this endeavor, I look forward to the future of the new site."
With its library of information on Medicare and enhanced layout, the new site's goal is to be a single stop on the Medicare education journey for many.
To discover the new MedicareFAQ.com, visit: https://www.medicarefaq.com/
About Elite Insurance Partners:
Founded in 2014, Elite Insurance Partners ranks in the top five Medicare brokerages in the nation. Representing over 30 carriers throughout the United States, their primary market is Medicare, but they also help with: dental, vision, cancer, heart attack, stroke, life, long-term care, and disability insurance. Assisting clients nationwide, their mission has always been simple: provide thorough education on all insurance options and help to find the best plan(s) for the needs and budget of each individual.
###
If you would like more information, please contact Lindsay Engle at LEngle@MedicareFAQ.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

PDA's Board of Directors is one of the most diverse in the pharmaceutical/biopharmaceutical industry.

BETHESDA, MD. (PRWEB) DECEMBER 11, 2020
The Parenteral Drug Association (PDA) today announced the results of the 2020 Board of Directors Election for the term beginning January 1, 2021. Members chose from a slate of candidates to fill three director positions, as the composition of the 2021 Executive Committee was determined in the 2019 BoD election.
The 2021 Board of Directors and Executive Committee is the most diverse in PDA's 70-year history, and features the only all-female team of Officers in the industry (winners of the 2020 election indicated in parentheses):
Executive Committee

Chair: Jette Christensen, Novo Nordisk

Chair-Elect: Susan Schniepp, RCA

Treasurer: Melissa Seymour, Biogen

Secretary: Emma Ramnarine, Genentech/Roche

Imm. Past Chair: Rebecca Devine, Regulatory Consultant

Directors

Barbara Allen, Eli Lilly and Company

Michael Blackton, Adaptimmune

Bettine Boltres, West Pharmaceutical Services (reelected)

Tia Bush, Amgen

Javier Camposano, Celltrion (appointed)

Ghada Haddad, Merck & Co.

Joyce Hansen, Johnson & Johnson

Stephan Krause, AstraZeneca Biologics

Mary Oates, Pfizer (reelected)

Mathias Romacker, Pfizer (ret.)

Anil Sawant, Merck & Co.

Osamu Shirokizawa, Lifescientia (elected)

"I want congratulate the new officers and directors and thank the many members who took the time to vote." said Richard Johnson, PDA President & CEO. "The diversity of our all-volunteer board of directors helps PDA continue to meet the needs of pharmaceutical and biopharmaceutical professions around the globe. I also want to thank the other candidates for their commitment to PDA."
PDA thanks outgoing directors Masahiro Akimoto, Otsuka Pharmaceutical Factory, Inc. and Stephan Roenninger, Amgen who will end their term at the end of 2020.
###
About PDA – Connecting People, Science and Regulation
The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its 10,000 members worldwide. Go to http://www.pda.org/footer/about-pda to learn more.




START your own Wordpress site, business or personal website, or online store at www.siteground.com

From Consumption Tracking to Behavioral Queue's, Ismokay Is The One-Of-A-Kind Resource Helping Smokers Worldwide Quit Smoking For Good

LOS ANGELES (PRWEB) DECEMBER 11, 2020
In the modern age, it is widely understood that smoking is unhealthy and can cause serious health complications, but the age-old question remains: what is the best way to quit? Due to scientific and technological advances over time, there are deeper insights into the habit of smoking and the physical and mental factors associated with it. Over the years there have been theories circulating over the best method to quit, but there has never been a reliable resource where smokers can seek help, motivation, and support; until now. Introducing Ismokay: the new one-of-a-kind app using behavioral change to help users quit smoking.
As the COVID-19 pandemic continues on, the human race has been force to adopt new habits, and abandon others. Social distancing, masks, and quarantines have become commonplace in this covid-era, but the shift is coincidentally helping individuals break bad habits. Many smokers claim they only smoke casually, but casual gatherings are becoming scarce and even taboo. Many smokers regularly hold a cigarette while outside in public, but now masks have become mandatory and this practice has become less common. Due to this, the pandemic has actually played a positive role in helping users fight the urge to pick up a pack of smokes.
Ismokay, has jumped in to push that initiative further and help users quit for good. This unique methodology uses specific journeys and behavioral changes, scientifically proven to create a lasting and meaningful change for those who commit to the process. Users of Ismokay will have the ability to:

Implement healthy habits to counteract smoking

Have access to guidelines for changing habits

Track their cigarette consumption, creating tables and visual representations of current and past smoking habits

Weekly guidance and motivation to stay on the right track

Select behavioral changes specific to each user to create a realistic and attainable goal in the journey to quit smoking for good

Through proof of concept, dedication to the methodology, and unwavering commitment to helping their users create lasting change; Ismokay's purpose-driven vision has come to fruition with the launch of this revolutionary mobile app set to change the face of the tobacco industry.
To learn more about Ismokay, please visit: https://ismokay.com/en/methodology/
About Ismokay
Ismokay is a mobile app created and dedicated to smokers in all paths of life. From the conscious smoker who wants to cut back, to those who need the motivation to keep the habit away, the Ismokay methodology involves the concept of behavioral changes, scientifically proven in several studies to help cut back or quit smoking altogether. By focusing on creating healthy habits at both the physical and emotional level, users of Ismokay can shift their behavior and take the "mind over matter" concept to fruition.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Keep Safe Care to offer health rides direct to consumers in Austin, Texas

AUSTIN, TEXAS (PRWEB) DECEMBER 12, 2020
Keep Safe Care, an innovative new non-medical in-home care agency, is now offering health rides as part of its partnership with Ride Health. As of December 1, 2020, Keep Safe Care of Central Austin (http://www.keepsafecare.com) began a pilot program with Ride Health (http://www.ridehealth.com) in the greater Austin, Texas area. As Americans are living longer and choosing to stay in their homes as they age, access to transportation for individuals who have mobility or cognitive issues can be challenging.
As people age, the ability to handle an automobile diminishes. Adding to the difficulties, fewer than 20% of the adult children in the United States live within 100 miles of their aging parents. In many cases, these adult children also have a family of their own to care for and taking mom or dad to doctor's appointments or to run errands is a scheduling nightmare. There is an ever-growing gap between mobility needs and mobility options for people unable to drive themselves or use a taxi or ride share programs.
Ride Health was created to address the pervasive problem of individuals with mobility issues who are unable to keep doctor's appointments or obtain their prescribed medications due to a lack of transportation options. Prior to engaging with Keep Safe Care, Ride Health addressed this situation by working exclusively with hospital and medical systems and allowing these entities to coordinate a ride for their clients to ensure appointments are kept or prescriptions are fulfilled.
"Ride Health is trying to simplify the complex transportation issues of people with mobility issues, including wheel chairs, walkers, canes and even those with cognitive decline", states Jeffrey Fry, Keep Safe Care's co-founder. "Ride Health's system requires a ride coordinator to schedule a ride. This is where Keep Safe Care can help. Acting as the ride coordinator, we are able to offer a suite of transportation options direct to consumers using this differentiated service."
Mr. Fry adds, "Keep Safe Care is very excited to offer this transportation offering to our clients and the public. We are able to leverage our expertise in technology with this partnership. Our extensive use of technology helps us match Careseekers with Caregivers, reducing the chronic problem of absenteeism and high staff turnover that face private duty agencies. The result is happier clients and happier Caregivers."
"Offering this very needed ride service helps differentiate the company in the private duty caregiving sector. Our agency software can handle the scheduling and billing of health rides and allows us to expand our capabilities while at the same time, reduce Keep Safe Care's liability of having our caregivers drive clients to appointments." states Stacey Berlow, Keep Safe Care's other co-founder.
Ride Health is already offering their service with Baylor Scott & White Healthcare in the greater Austin area including Travis, Williamson, and Hays counties. This covers its full suite of rides including door-to-door assistance, wheelchair accessible vehicles, stretcher vans, and ALS/BLS ambulances.
About Ride Health
Ride Health partners with healthcare organizations and transportation network providers to manage transportation benefits, strengthen enterprise transportation programs, and drive intelligent transitions of care. The company blends technology and data with a human approach to break down access barriers and solve some of the biggest transportation challenges that care coordinators, providers, and payers face. Their platform maps out each patient's unique needs and preferences for the best ride experience across clinical and social needs, ensuring greater access, improved efficiencies, lower costs, and better outcomes. Learn more at http://www.ridehealth.com
About Keep Safe Care
Keep Safe Care is modernizing in-home caregiving by empowering Careseekers (both individuals and families looking for someone to help care for their parents or loved ones) and caregivers in the caregiving process. The company's extensive use of technology both improves care coordination and accountability and reduces the chronic problems of caregiver absenteeism and turnover. This innovation gives families and loved ones a greater say on how care is delivered, resulting in more reliable, dependable and consistence caregiving. For more information including flexible pricing and care services offered visit http://www.keepsafecare.com.
Media Contact
Stacey Berlow
sberlow@keepsafecare.com
(512) 522-2771



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Highmark and Boehringer Ingelheim announced positive results from their outcomes-based agreement, which showed that adults with type 2 diabetes and known cardiovascular disease who took Jardiance (empagliflozin) had a lower annual total cost of care compared with those prescribed other branded or generic anti-hyperglycemic medications. Patients on Jardiance demonstrated a reduction in medical costs of over 30%. Factoring in both medical and pharmacy costs, the overall total cost of care reduction was more than 20% for patients on Jardiance.

PITTSBURGH, AND RIDGEFIELD, CONN. (PRWEB) DECEMBER 15, 2020
Highmark and Boehringer Ingelheim announced positive results from their outcomes-based agreement, which showed that adults with type 2 diabetes and known cardiovascular disease who took Jardiance (empagliflozin) had a lower annual total cost of care compared with those prescribed other branded or generic anti-hyperglycemic medications. Jardiance is an oral prescription medicine indicated along with diet and exercise to lower blood sugar in adults with type 2 diabetes and to reduce the risk of cardiovascular death in adults with type 2 diabetes who have known cardiovascular disease. Jardiance is not for people with type 1 diabetes or for people with diabetic ketoacidosis (increased ketones in the blood or urine). Please see Important Safety Information below. Jardiance is a product in the Boehringer Ingelheim and Eli Lilly and Company alliance portfolio.
The innovative outcomes-based agreement, launched in 2018, was designed to evaluate the total cost of care for in-scope patients over a one-year period, using actuarial analytical methods. In the retrospective analysis of pharmacy and medical claims for adults with type 2 diabetes and known cardiovascular disease, the patients on Jardiance demonstrated a reduction in medical costs of over 30%. Factoring in both medical and pharmacy costs, the overall total cost of care reduction was more than 20% for patients on Jardiance.
"The results of our outcomes-based agreement with Highmark demonstrated that Jardiance can help reduce the economic burden of type 2 diabetes and cardiovascular disease, underscoring its value to the healthcare system," said Christine Marsh, senior vice president, Market Access, Boehringer Ingelheim Pharmaceuticals, Inc. "We are proud of our unique partnership with Highmark and our efforts show how pharmaceutical companies and payors can work together to ensure people living with these chronic, debilitating conditions get the best, guideline-directed care while lowering total medical costs."
"Highmark is committed to developing solutions that provide access to treatments that improve outcomes and reduce the total cost of care for chronic conditions like diabetes and heart disease, which have a huge impact on our members and on our healthcare system," said Kayse Reitmeyer, Manager of Pharmacy Contracting, Highmark. "The reduction in medical costs seen in this analysis may stem from fewer medical and hospital interventions related to diabetes and heart disease for Highmark members in the Jardiance group. We are pleased with the results of our outcomes-based agreement with Boehringer Ingelheim, and we look forward to applying these insights to continue ensuring access to products that provide both clinical and cost savings benefits for our members."
Over 34 million Americans are living with diabetes, with type 2 diabetes accounting for 90 to 95% of all cases. Type 2 diabetes is associated with an increased risk of cardiovascular disease and its complications. Type 2 diabetes and its complications impose a huge burden on the healthcare system. Annual medical expenses for people with diagnosed diabetes in 2017 was $237 billion representing a 26% increase over a five-year period, and costs for cardiovascular disease are projected to rise to more than $1 trillion by 2035.
About Type 2 Diabetes and Cardiovascular Disease
Diabetes is a chronic condition that occurs when the body either does not properly produce, or use, the hormone insulin. More than 463 million people worldwide have diabetes, of which 232 million are estimated to be undiagnosed. By 2045, the number of people with diabetes is expected to rise to 700 million people worldwide. Type 2 diabetes is the most common form of diabetes.
Due to the complications associated with diabetes, such as high blood sugar, high blood pressure and obesity, cardiovascular disease is a major complication and the leading cause of death associated with diabetes. One in two people with type 2 diabetes worldwide die from a cardiovascular event.
What is JARDIANCE? (http://www.jardiance.com)
JARDIANCE is a prescription medicine used along with diet and exercise to lower blood sugar in adults with type 2 diabetes.
JARDIANCE is also used to reduce the risk of cardiovascular death in adults with type 2 diabetes who have known cardiovascular disease.
JARDIANCE is not for people with type 1 diabetes or for people with diabetic ketoacidosis (increased ketones in the blood or urine).
IMPORTANT SAFETY INFORMATION
Do not take JARDIANCE if you are allergic to empagliflozin or any of the ingredients in JARDIANCE.
Do not take JARDIANCE if you have severe kidney problems or are on dialysis.
JARDIANCE can cause serious side effects, including:

    Dehydration. JARDIANCE can cause some people to have dehydration (the loss of body water and salt). Dehydration may cause you to feel dizzy, faint, light-headed, or weak, especially when you stand up.

You may be at a higher risk of dehydration if you:

    have low blood pressure

    take medicines to lower your blood pressure, including water pills (diuretics)

    are on a low salt diet

    have kidney problems

    are 65 years of age or older.

    Vaginal yeast infection. Women who take JARDIANCE may get vaginal yeast infections. Talk to your doctor if you experience vaginal odor, white or yellowish vaginal discharge (discharge may be lumpy or look like cottage cheese), and/or vaginal itching.

    Yeast infection of the penis. Men who take JARDIANCE may get a yeast infection of the skin around the penis, especially uncircumcised males and those with chronic infections. Talk to your doctor if you experience redness, itching or swelling of the penis, rash of the penis, foul smelling discharge from the penis, and/or pain in the skin around penis.

    Ketoacidosis (increased ketones in your blood or urine). Ketoacidosis is a serious condition and may need to be treated in the hospital. Ketoacidosis may lead to death. Ketoacidosis occurs in people with type 1 diabetes and can also occur in people with type 2 diabetes taking JARDIANCE, even if blood sugar is less than 250 mg/dL. Ketoacidosis has also happened in people with diabetes who were sick or who had surgery during treatment with JARDIANCE. Stop taking JARDIANCE and call your doctor right away if you get any of the following symptoms, and if possible, check for ketones in your urine:

    nausea        

    vomiting

    stomach-area (abdominal) pain

    tiredness

    trouble breathing

    Kidney problems. Sudden kidney injury has happened in people taking JARDIANCE. Talk to your doctor right away if you reduce the amount you eat or drink, or if you lose liquids; for example, from vomiting, diarrhea, or being in the sun too long.

    Serious urinary tract infections. Serious urinary tract infections can occur in people taking JARDIANCE and may lead to hospitalization. Tell your doctor if you have symptoms of a urinary tract infection, such as a burning feeling when passing urine, a need to urinate often or right away, pain in the lower part of your stomach or pelvis, or blood in the urine. Sometimes people also may have a fever, back pain, nausea or vomiting.

    Low blood sugar (hypoglycemia): If you take JARDIANCE with another medicine that can cause low blood sugar, such as sulfonylurea or insulin, your risk of low blood sugar is higher. The dose of your sulfonylurea or insulin may need to be lowered. Symptoms of low blood sugar may include:

o    headache
o    drowsiness
o    weakness
o    dizziness
o    confusion
o    irritability
o    hunger
o    fast heartbeat
o    sweating
o    shaking or feeling jittery

    Necrotizing fasciitis. A rare but serious bacterial infection that causes damage to the tissue under the skin in the area between and around your anus and genitals (perineum). This bacterial infection has happened in women and men who take JARDIANCE, and may lead to hospitalization, multiple surgeries, and death. Seek medical attention immediately if you have fever or are feeling very weak, tired or uncomfortable (malaise), and you develop any of the following symptoms in the area between and around your anus and genitals: pain or tenderness, swelling, and redness of skin (erythema).

    Allergic (hypersensitivity) reactions. Symptoms of serious allergic reactions to JARDIANCE may include:

    swelling of your face, lips, throat and other areas of your skin

    difficulty with swallowing or breathing

    raised, red areas on your skin (hives)

If you have any of these symptoms, stop taking JARDIANCE and contact your doctor or go to the nearest emergency room right away.

    Increased fats in your blood (cholesterol).

The most common side effects of JARDIANCE include urinary tract infections and yeast infections in females.
These are not all the possible side effects of JARDIANCE. For more information, ask your doctor or pharmacist.
Before taking JARDIANCE, tell your doctor if you:

    have kidney problems. Your doctor may do blood tests to check your kidneys before and during your treatment with JARDIANCE

    have liver problems

    have a history of urinary tract infections or problems with urination

    are going to have surgery. Your doctor may stop your JARDIANCE before you have surgery. Talk to your doctor if you are having surgery about when to stop taking JARDIANCE and when to start it again

    are eating less or there is a change in your diet

    have or have had problems with your pancreas, including pancreatitis or surgery on your pancreas

    drink alcohol very often, or drink a lot of alcohol in the short term ("binge" drinking)

    have any other medical conditions

    are pregnant or plan to become pregnant. JARDIANCE may harm your unborn baby. Tell your doctor right away if you become pregnant during treatment with JARDIANCE

    are breastfeeding or are planning to breastfeed. JARDIANCE may pass into your breast milk and may harm your baby. Do not breastfeed while taking JARDIANCE

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Especially tell your doctor if you take water pills (diuretics) or medicines that can lower your blood sugar, such as insulin.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.fda.gov/medwatch or call 1-800-FDA-1088.
For more information, please see Prescribing Information and Medication Guide.
CL-JAR-100057 01.27.2020
About Highmark Inc.
One of America's leading health insurance organizations and an independent licensee of the Blue Cross Blue Shield Association, Highmark Inc. (the Health Plan) and its affiliated health plans (collectively, the Health Plans) work passionately to deliver high-quality, accessible, understandable, and affordable experiences, outcomes, and solutions to customers. As the fourth-largest overall Blue Cross Blue Shield-affiliated organization, Highmark Inc. and its Blue-branded affiliates proudly cover the insurance needs of more than 5.6 million members in Pennsylvania, Delaware, and West Virginia. Its diversified businesses serve group customer and individual needs across the United States through dental insurance and other related businesses. For more information, visit http://www.highmark.com.
About Boehringer Ingelheim
Making new and better medicines for humans and animals is at the heart of what we do. Our mission is to create breakthrough therapies that change lives. Since its founding in 1885, Boehringer Ingelheim is independent and family-owned. We have the freedom to pursue our long-term vision, looking ahead to identify the health challenges of the future and targeting those areas of need where we can do the most good.
As a world-leading, research-driven pharmaceutical company, more than 51,000 employees create value through innovation daily for our three business areas: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. In 2019, Boehringer Ingelheim achieved net sales of around $21.3 billion (19 billion euros). Our significant investment of over $3.9 billion (3.5 billion euros) in R&D drives innovation, enabling the next generation of medicines that save lives and improve quality of life.
We realize more scientific opportunities by embracing the power of partnership and diversity of experts across the life-science community. By working together, we accelerate the delivery of the next medical breakthrough that will transform the lives of patients now, and in generations to come.
Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation and is part of the Boehringer Ingelheim group of companies. In addition, there are Boehringer Ingelheim Animal Health in Duluth, GA and Boehringer Ingelheim Fremont, Inc. in Fremont, CA.
Boehringer Ingelheim is committed to improving lives and strengthening our communities. Please visit http://www.boehringer-ingelheim.us/csr to learn more about Corporate Social Responsibility initiatives.
For more information, please visit http://www.boehringer-ingelheim.us, or follow us on Twitter @BoehringerUS.
###
Jardiance is a registered trademark of Boehringer Ingelheim.
MPR-US-101440
CONTACT:
Leilyn Perri
Highmark Health    
717-215-7835
Leilyn.perri@highmarkhealth.org
CONTACT:
Sheryl van der Hilst
Senior Associate Director, Public Relations
Boehringer Ingelheim Pharmaceuticals, Inc.
914-772-7973
sheryl.van_der_hilst@boehringer-ingelheim.com

We look forward to applying these insights to continue ensuring access to products that provide both clinical and cost savings benefits for our members-Kayse Reitmeyer, Manager of Pharmacy Contracting, Highmark



START your own Wordpress site, business or personal website, or online store at www.siteground.com